DNB ASSET MANAGEMENT AS – BioMarin Pharmaceutical Inc. Transaction History
DNB ASSET MANAGEMENT AS portfolio value:
$10.24M
portfolio value
DNB ASSET MANAGEMENT AS quarter portfolio value change:
+2.29%
quarter
BioMarin Pharmaceutical Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -29.41% | -50.35K shares | -3.94M | $84.77 | 120.83K |
| Q2 2022 | share | Decrease | -1.75% | -3.05K shares | 752.58K | $82.87 | 171.18K |
| Q1 2022 | share | Increase | +3.41% | 5.74K shares | -1.45M | $77.1 | 174.23K |
| Q4 2021 | share | Increase | +15.21% | 22.24K shares | 3.58M | $89.08 | 168.49K |
| Q3 2021 | share | Increase | +17.61% | 21.89K shares | 927.75K | $77.29 | 146.24K |
| Q2 2021 | share | Increase | +82.47% | 56.20K shares | 5.22M | $83.44 | 124.34K |
| Q1 2021 | share | Increase | +16.60% | 9.7K shares | 20.56K | $75.51 | 68.14K |
| Q4 2020 | share | Increase | +79.51% | 25.88K shares | 2.64M | $87.69 | 58.44K |
| Q3 2020 | share | Decrease | -69.10% | -72.80K shares | -10.51M | $76.08 | 32.56K |
| Q2 2020 | share | Increase | +16.05% | 14.57K shares | 5.32M | $123.34 | 105.36K |
| Q1 2020 | share | Decrease | -3.23% | -3.03K shares | -260.89K | $84.5 | 90.79K |
| Q4 2019 | share | Increase | +411.49% | 75.48K shares | 6.69M | $84.55 | 93.82K |
| Q3 2019 | share | Increase | +8.97% | 1.51K shares | -205.42K | $67.4 | 18.34K |
| Q2 2019 | share | Decrease | -8.46% | -1.55K shares | -191.74K | $85.65 | 16.83K |
| Q1 2019 | share | Decrease | -10.16% | -2.08K shares | -109.44K | $88.83 | 18.38K |
| Q4 2018 | share | Decrease | -6.11% | -1.33K shares | -371.01K | $85.15 | 20.46K |
| Q3 2018 | share | Increase | +4.81% | 1K shares | 154.58K | $96.97 | 21.8K |
| Q2 2018 | share | Increase | +4.00% | 800 shares | 337.96K | $94.2 | 20.8K |
| Q1 2018 | share | Increase | +9.29% | 1.7K shares | -10.41K | $81.07 | 20K |
| Q4 2017 | share | 0.00% | 0 shares | -71.37K | $89.17 | 18.3K | |
| Q3 2017 | share | 0.00% | 0 shares | 41.17K | $93.07 | 18.3K | |
| Q2 2017 | share | Decrease | -3.68% | -700 shares | -5.81K | $90.82 | 18.3K |
| Q1 2017 | share | Increase | +17.28% | 2.8K shares | 325.81K | $87.78 | 19K |
| Q4 2016 | share | Increase | +23.66% | 3.1K shares | 129.99K | $82.84 | 16.2K |
| Q3 2016 | share | Increase | +2.34% | 300 shares | 216.17K | $92.52 | 13.1K |
| Q2 2016 | share | Increase | +2.40% | 300 shares | -35.16K | $77.8 | 12.8K |
| Q1 2016 | share | Increase | 0.00% | 12.5K shares | 1.03M | $82.48 | 12.5K |